Bruce Keyt Igm Biosciences, Inc. (IGMS) insider trading activity

Bruce Keyt is CHIEF SCIENTIFIC OFFICER of IGM Biosciences, Inc.. Currently has a direct ownership of 242,948 shares of IGMS, which is worth approximately $3.17 Million. The most recent transaction as insider was on Sep 01, 2021, when has been sold 1,256 shares (Common Stock) at a price of $71.79 per share, resulting in proceeds of $90,168. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K

0.61% 3M change

75.98% 12M change

Total Value Held $3.17 Million

Bruce Keyt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 01 2021	SELL Payment of exercise price or tax liability	$90,168 $71.79 p/Share	1,256 Reduced 22.6%	4,301 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
Aug 04 2021	SELL Open market or private sale	$83,214 $67.0 p/Share	1,242 Reduced 28.89%	3,057 Common Stock
Aug 02 2021	SELL Payment of exercise price or tax liability	$84,236 $66.96 p/Share	1,258 Reduced 22.64%	4,299 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
Jul 06 2021	SELL Open market or private sale	$102,878 $82.5 p/Share	1,247 Reduced 28.97%	3,057 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$112,056 $89.43 p/Share	1,253 Reduced 22.55%	4,304 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
Jun 02 2021	SELL Open market or private sale	$98,542 $79.15 p/Share	1,245 Reduced 28.94%	3,057 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$100,387 $79.99 p/Share	1,255 Reduced 22.58%	4,302 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	$13,219 $45.9 p/Share	288 Added 8.61%	3,057 Common Stock
May 05 2021	SELL Open market or private sale	$77,688 $62.5 p/Share	1,243 Reduced 30.98%	2,769 Common Stock
May 03 2021	SELL Payment of exercise price or tax liability	$85,514 $68.03 p/Share	1,257 Reduced 23.86%	4,012 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 32.18%	5,269 Common Stock
Apr 06 2021	SELL Open market or private sale	$102,828 $82.0 p/Share	1,254 Reduced 31.17%	2,769 Common Stock
Apr 05 2021	SELL Payment of exercise price or tax liability	$103,916 $83.4 p/Share	1,246 Reduced 23.65%	4,023 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 32.18%	5,269 Common Stock
Mar 02 2021	SELL Open market or private sale	$146,115 $90.25 p/Share	1,619 Reduced 36.9%	2,769 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$81,440 $92.44 p/Share	881 Reduced 16.72%	4,388 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 32.18%	5,269 Common Stock
Feb 03 2021	SELL Open market or private sale	$155,424 $96.0 p/Share	1,619 Reduced 36.9%	2,769 Common Stock
Feb 02 2021	SELL Payment of exercise price or tax liability	$84,928 $96.4 p/Share	881 Reduced 16.72%	4,388 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 32.18%	5,269 Common Stock
Jan 05 2021	SELL Open market or private sale	$119,233 $79.33 p/Share	1,503 Reduced 35.18%	2,769 Common Stock

Bruce Keyt

CHIEF SCIENTIFIC OFFICER

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Value

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS

Account